Tendencia en Estados Unidos

Most men who lose firmness don't have an erection problem. They have a circulation problem no one ever diagnosed.

Routine tests don't catch it. The annual checkup doesn't ask about it. And yet it's the physical cause behind most cases after age forty-five.

7,791 Reseñas
Dr. Fernando Salazar
Escrito por el Dr. Fernando Salazar, Cardiólogo Certificado |

The medical system is lying to you about your erection problem.

 

Your doctor is only repeating what he was taught.

 

Not because he wants to deceive you.

 

Simply because they never gave him any other answer to give you.

 

Every time he writes you a prescription for Viagra and tells you "this should help you," there's a sentence that stays in his head and never reaches yours:

 

That pill isn't curing anything.

 

It's buying time.

 

Each dose gives you a few hours of borrowed performance — while, on the inside, your arteries keep hardening.

 

Month after month.

 

No warning. No pain. And no test catches it until it's already too late.

 

I say this as a cardiologist.

 

And I say it because I've seen it too many times.

 

I see it at 40.

 

I see it at 55.

 

I see it at 62.

 

Men who walk into my office with the prescription in hand and the same question in their eyes:

 

"Is this all there is, doctor?"

 

And I know it isn't. I've known for years. 

 

But we don't tell you, because there is no patentable drug we can sell you for the real problem.

 

Until now. Until this text.

Every value in range, and the same problem

A fifty-five-year-old man goes in for his annual checkup.

 

They take his blood pressure. They order a full lipid panel, fasting blood glucose, kidney and liver function. They check his weight and his waist circumference. In some cases, a resting electrocardiogram.

 

He leaves with every value within range and with instructions to lose two kilos.

 

At no point was the one thing that had been worrying him for months evaluated. And he didn't bring it up either, because in a ten-minute appointment, with the door opening and closing, it is hard to know where to start with that.

 

He went home with normal test results and with the same problem he came in with.

 

This is the most frequent scenario, and it is worth understanding why it happens.

 

It is not a matter of negligence. Routine tests are designed to detect overt disease: an elevated blood glucose, a cholesterol out of range, an insufficiency already underway. They are good at that.

 

What we are describing is not an overt disease. It is a function that is deteriorating progressively, and functions that deteriorate do not produce an abnormal value in a tube of blood. They produce symptoms before they produce numbers.

 

There is something else, and it is what explains most of the delay in identifying it: it is the only vascular symptom the patient does not report.

 

A man who feels tightness in his chest going up a flight of stairs says so. A man who notices heaviness in his legs after walking three blocks says so. 

 

A man who has not managed a full erection in two years does not say so, not to his doctor and not to anyone.

 

And so the earliest indicator the cardiovascular system has ends up being the only one that never makes it to the doctor's office.

The five indicators that show up before any test does

Even though routine tests don't detect it, the process leaves observable signs. They are consistent and almost always appear in the same order.

 

First: the disappearance of spontaneous erections on waking.

 

It's the earliest indicator and the one most often ignored. During sleep, in the rapid eye movement phases, the body produces several episodes of reflex erection.

 

They don't depend on desire or on any stimulus at all: they are an involuntary process that occurs between three and five times a night.

 

Their physiological function is precisely the oxygenation of the tissue. When dilation capacity begins to decline, these episodes are the first to disappear, because they don't have the reinforcement of conscious arousal.

 

Their absence is a sign, and almost nobody remembers when they stopped happening, because the process is gradual.

 

Second: an erection that starts properly and doesn't hold.

 

The process begins normally and is lost within a few minutes. This points to something specific: the inflow is arriving, but it is not being retained.

 

An erection requires two things at the same time: that the arteries dilate so the blood comes in, and that the resulting pressure compress the outflow veins so it stays. 

 

If the inflow is insufficient, that pressure never reaches the necessary threshold, and the system fails to close.

 

Third: the need for increasing stimulation.

 

What used to happen spontaneously now requires a greater stimulus, more direct and more prolonged. The response is still possible, but it needs more signal to activate.

 

Fourth: anticipatory avoidance.

The man stops initiating the situation so as not to expose himself to it happening again. He cuts back on physical contact that could be read as an advance. He adjusts his sleep schedule.

 

This is neither a cause nor a symptom of the physiological process: it is a behavioral response to repeated failure, and it creates a parallel problem that we will look at later on.

 

Fifth: attribution to external factors.

Accumulated tiredness, work stress, schedules, excess weight, age. All plausible explanations, and all present in the life of any man that age.

 

That plausibility is what keeps him from looking for the real cause. As long as an acceptable explanation is available, nobody investigates any further.

 

These five signs are not a failure of will, nor a problem of psychological origin.

 

The distinction matters and it has a practical test: if the spontaneous erections during sleep have disappeared, the component is not psychological. 

 

Those episodes occur without conscious participation. If the process that requires no desire also fails, the cause is in the mechanism, not in the head.

The anatomical reason for the gap between the symptom and the diagnosis

There is a structural explanation for why these indicators appear while all the general parameters remain normal. 

 

It's a question of caliber.

 

The arteries that have to dilate for an erection to occur are approximately one to two millimeters in diameter.

 

The coronary arteries, the ones that supply the heart muscle, measure between three and four millimeters. The carotids, which carry blood to the brain, between five and seven.

 

That difference in caliber has a direct and predictable consequence.

 

When a vessel's capacity to dilate begins to decline, the loss of interior lumen proportionally affects the smaller-diameter vessels far more. A thickening of the wall that in a coronary artery reduces flow only marginally can cut it in half in a one-millimeter artery.

 

Put another way: the same degree of deterioration produces a noticeable effect in the finest territory, and none in the rest.

 

This makes this function an early indicator.

 

The vascular literature has described it for decades: impairment in the penile territory usually precedes by several years the appearance of the same process in larger-caliber territories. 

 

Not because they are different things, but because it is the same process, observed at the point where it shows up first.

 

That's why the progression most men attribute to age has such a consistent shape:

 

At thirty, the response is spontaneous. It requires no particular conditions, no concentration, no absence of distractions.

 

At forty, the need for attention appears. The process still happens, but it's no longer completely automatic.

 

At forty-five, the response takes longer to start and holds for less time. The first failed occasions begin, generally attributed to tiredness.

 

At fifty, it frequently no longer completes, and the failures stop being occasional.

That sequence reads like an age curve.

 

It corresponds far more precisely to the evolution of vascular dilation capacity.

What the endothelium is and why it determines everything else

To understand what exactly deteriorated, we have to talk about a structure almost no one mentions outside specialized circles.

 

The inside of every blood vessel is lined with a layer of cells one cell thick. 

 

It's called the endothelium. If an adult's endothelium were spread out on a flat surface, it would cover several hundred square meters.

 

For much of the twentieth century, that layer was considered to be nothing more than a lining, a smooth surface for blood to flow through without friction.

 

Today it is considered an organ. One of the largest in the body, and probably the one the average patient knows least about.

 

Its main function is to produce chemical signals that regulate how the vessel behaves. And the most important of those signals is a gas molecule called nitric oxide.

 

What nitric oxide does:

 

It is produced in the endothelial cell and crosses into the vessel's muscle layer, where it gives a single instruction: for the muscle to relax.

 

When the muscle relaxes, the vessel dilates. When the vessel dilates, more blood comes in. No dilation is possible without that signal.

 

Its discovery as a signaling molecule of the cardiovascular system received the Nobel Prize in Medicine in nineteen ninety-eight.

 

And it has two characteristics that define everything else in this article:

 

First: it is not stored. Its half-life is measured in seconds. The body holds no reserves. It either produces it continuously or it doesn't have it.

 

Second: its availability is not the same as its production. What is available at any given moment is the result of a subtraction between what is produced and what is degraded before it reaches its destination.

 

That subtraction is at the center of everything that follows.

Why production falls and loss rises at the same time

With age and accumulated exposure to risk factors, this capacity deteriorates. But it doesn't do so along a single path: it does so along two, and simultaneously.

 

First side: production decreases.

 

The enzyme responsible for synthesizing nitric oxide in the endothelium is called endothelial nitric oxide synthase, or eNOS by its usual abbreviation.

 

To work properly it needs to have substrate and certain cofactors available. Over the years, and under conditions of sustained oxidative stress, the availability of those cofactors decreases.

 

When that happens, something occurs that is worth understanding well: the enzyme doesn't simply produce less. It starts producing something else.

 

Under conditions of cofactor deficiency, eNOS uncouples and, instead of generating nitric oxide, begins to generate superoxide radical, which is precisely the compound that destroys nitric oxide.

 

The factory doesn't just lower its output. It starts manufacturing the contaminant.

 

Second side: degradation increases.

 

At the same time, the overall oxidative load on the endothelium rises. And superoxide radical reacts with nitric oxide at an extraordinary speed: it is one of the fastest reactions known in biology, limited only by the speed at which the two molecules manage to find each other.

 

That means the nitric oxide produced doesn't have time to do its job if there's superoxide in the way. It's used up first.

 

The product of that reaction, moreover, is not inert: it's an oxidizing compound that contributes to degrading the enzyme's capacity even further.

 

This sets up a circuit that feeds on itself.

 

Fewer cofactors produce more superoxide. More superoxide destroys more nitric oxide and does more damage to the enzyme. A more damaged enzyme produces even more superoxide.

 

And this is the reason the process speeds up over the years instead of advancing in a linear fashion. 

 

It's not that the body ages uniformly: it's that this specific circuit feeds back into itself.

Why increasing production has a ceiling

From everything above follows a simple formulation, and it is probably the most useful idea in this article:

 

Available nitric oxide = what is produced − what is degraded before it acts.

 

It's a subtraction. And like any subtraction, the result depends on both terms.

 

Now it's worth looking at what the products available on the market do.

 

Products aimed at this goal work, almost without exception, on the first term. They supply precursors. They supply substrate. They supply raw material so the enzyme produces more.

 

It's a reasonable strategy and it works up to a point.

 

The problem is that the second term doesn't change.

 

If a body produces a given amount and degrades a high proportion of it before it acts, increasing production raises the result by the same proportion, not in absolute terms. The loss scales along with the intake.

 

And this explains something many men describe that is usually misread.

 

The pattern is always the same: a man starts a supplement in this category, feels an effect over the first few weeks, and then the effect fades.

 

The usual interpretation is that the product was bad, or that the body got used to it.

 

Neither one is accurate. The intake was right and still is. What happens is that the system doing the degrading keeps operating at the same intensity, and as the oxidative load rises, it takes up a growing fraction of what is supplied.

 

More is produced. More is lost. The net result goes back to where it started.

 

A complete intervention requires acting on both terms. Increasing what is produced, and reducing what is lost.

 

That is what defines the difference between a formula that performs for weeks and one that sustains the result over time.

VERIFICAR DISPONIBILIDAD

The parallel problem that sustains itself

There is a consequence of this process that does not show up in any clinical evaluation and that is often more significant than the symptom that caused it.

 

Go back to the fourth indicator in the previous section: anticipatory avoidance.

 

It is a logical behavioral response. After two or three failed episodes, the man reduces his exposure to the situation that produces them. It is not a deliberate decision: it is a gradual adjustment. 

 

He goes to bed later. He avoids the physical contact that could be read as an initiation. He finds reasonable reasons for the situation not to come up.

 

The problem is what happens on the other side.

 

His partner observes a sustained change in behavior. She has no access to the cause, because he did not tell her. And in the absence of an explanation, the human brain produces one: disinterest, distance, that something changed, that there is someone else, that she has stopped being attractive to him.

 

A second problem is then established, entirely different in nature from the first, and one that no longer depends on him.

 

And this second problem has a feature that makes it particularly difficult: it sustains itself even if the first one is resolved.

 

A man who recovers function after three years of withdrawal does not find the situation where he left it. He finds a relationship that reorganized itself around his absence, with habits, distances and explanations already in place.

 

This is the practical reason why it is worth identifying the physical cause early. Not only because of function itself, but because every month that goes by without an explanation has a cost of its own that is not reversed as easily.

 

Exactly what they do, and what their limit is

It's worth spelling out what happens with immediate-action products, because their behavior is frequently misread.

 

Their mechanism does not consist of producing nitric oxide.

It consists of temporarily inhibiting the enzyme that degrades the downstream signal of the nitric oxide already present. In practical terms: they keep the signal that already exists from switching off, for a few hours.

 

Three consequences follow from that mechanism, none of which is a criticism of the product:

 

First. Their effect is capped by what the body still produces.

 

If endogenous production is low, so is the margin there is to act on. The molecule amplifies an existing signal; it doesn't create it. That's why its effectiveness drops in the cases where production is most compromised, which is exactly where it would be needed most.

 

Second. The effect ends when the compound's action ends.

 

The physiological situation goes back to where it was before. No capacity is left in place, there is no buildup, there is no improvement in the baseline. Every episode requires taking it again.

 

Third. The dose needed tends to increase over time.

 

Not because pharmacological tolerance develops in the strict sense, but because the underlying process keeps advancing. If endogenous production keeps declining year after year, the same dose acts on a smaller and smaller base.

 

None of these three observations disqualifies the product. 

 

They describe precisely what it does: it acts on the momentary availability of a signal, not on the capacity to generate it.

 

It's the difference between amplifying a weak signal and repairing the transmitter.

 

And what that setup doesn't change is the process described in the earlier sections, which keeps running its course no matter how many times the signal is amplified.

 

That process does allow for intervention. The following sections describe how.

What has to happen for the equation to change

An intervention on the process described requires acting at three different points in the same circuit. 

 

All three are necessary and none of them replaces the others.

 

First point: supply through a pathway that doesn't depend on the compromised enzyme.

 

There is a second route of nitric oxide production, independent of eNOS.

 

The nitrate present in certain vegetables follows a conversion sequence that ends in nitric oxide without requiring the participation of the endothelial enzyme. 

 

It doesn't need its cofactors, it doesn't compete for its substrates, and it isn't affected by its uncoupling.

 

That independence is what makes it relevant in this specific context: it keeps its capacity to supply precisely in the body where the enzymatic pathway is already performing below optimal.

 

There is one additional detail that reinforces its usefulness. This route becomes more efficient under conditions of lower oxygen availability and reduced pH, which are exactly the conditions found in a territory with compromised flow.

 

Put another way: the alternative pathway performs best exactly where the main one performs worst.

The concentrated source of that nitrate is beetroot.

 

 

Second point: restoring your own productive capacity.

 

An outside supply solves the present. It doesn't solve the capacity.

For that you have to act on the enzyme itself, and that's where the polyphenols in grape seed extract come in, on two different levels:

 

They promote its activation, increasing production from the enzyme already available.

 

And they increase its expression, which is the truly significant part: they increase the amount of enzyme the cell produces.

 

The distinction between the two is what defines the long-term result.

 

An activation stimulus pays off while the stimulus is present. An increase in expression restores installed capacity, and that capacity stays.

 

It's the difference between making the existing factory work harder and building more factory.

 

Of the three components, this is the only one that acts on the sender and not on the signal.

Third point: reducing degradation.

 

This addresses the second term of the subtraction, which is the one the available offerings usually don't touch.

 

The punicalagins in pomegranate extract strengthen the endothelium's antioxidant defense and reduce the superoxide radical load.

 

This has two chained effects:

 

The first is direct. Less superoxide means that a greater proportion of the nitric oxide produced reaches the muscle layer and does its job.

 

The second is indirect and more important. Less superoxide also means less accumulated damage to the enzyme, which reduces its uncoupling. The intervention is on the loop that feeds itself, not just on one of its effects.

 

And it operates on the total: it protects nitric oxide of dietary origin and nitric oxide from the body's own synthesis equally.

 

Taken together: a supply that doesn't depend on the compromised enzyme, restoration of the enzyme itself, and reduction of the loss that affects both.

 

The three points of the same circuit. None of the three, on its own, changes the whole equation.

Why there was no formula that did all three things

At this point it is worth asking a reasonable question: if the mechanism is described and the three points of intervention are known, why aren't there ten products on the market that cover them?

 

The answer is not medical. It is industrial, and it has three parts.

 

First: the second term of the equation cannot be sold on its own.

 

An ingredient that increases production has a communicable promise. "More nitric oxide" fits on a label and anyone understands what it means.

 

An ingredient that reduces degradation does not have that advantage. Its benefit is not perceived in isolation: it is perceived in combination with what it protects. On its own, a consumer who takes it will not notice anything attributable to it.

 

That makes it a poor standalone product. And an industry organized around standalone products has no incentive to develop something whose value only appears alongside something else.

 

Second: standardization multiplies the cost.

 

An extract with no declared percentage and a standardized extract are not the same product, even though on the label they take up the same line.

 

Obtaining an extract with a guaranteed concentration of active compound requires a controlled extraction process, analysis of every batch, and discarding the material that does not reach the threshold. 

 

The cost per kilo multiplies several times over compared with the generic extract.

 

In a category where competition is settled on the shelf price, the manufacturer that standardizes loses the comparison against the one that does not. The consumer sees two bottles that say the same thing and picks the cheaper one.

 

The commercial conclusion is predictable: don't standardize.

 

Third: three well-dosed components cost more than fifteen token ones.

 

It may seem counterintuitive, but it is simple arithmetic.

 

Including fifteen ingredients at minimal doses —just enough to name them on the label— costs less than including three in the amount the mechanism requires. And visually, fifteen is more impressive.

 

That is why the dominant format in the category is the long formula with token doses. It is not a design mistake: it is the rational response to what the consumer rewards on the shelf.

 

Together, these three conditions explain the current state of what is on offer.

 

There is no guarded secret and no conspiracy. There is a set of incentives that consistently pushes toward the same place: long formulas, generic extracts, and intervention on a single term of the equation.

 

That is the reason a formula that covers all three points has to be developed from scratch, and is not found ready-made on the shelf.

 

It also explains why its price cannot be compared with that of a bottle of ground beetroot. They are not the same product, even though both labels mention the same plant.

 

Four criteria for evaluating any product in this category

Before describing the formulation we developed, it's worth setting out the criteria by which any product in this category should be evaluated. This one included.

 

One. Dose declared for each component.

 

If the label says "proprietary blend" followed by a total, there is no way to determine how much of each ingredient is in there. The ratio can heavily favor the lowest-cost components, and there is no way to verify it from the outside.

 

The usual justification for this practice is protecting the formula from competitors. In practice it works as protection from the consumer.

 

Two. Standardization of the extracts.

 

"Pomegranate extract" tells you nothing about concentration. "Pomegranate extract standardized to forty percent punicalagins" does.

 

Without that percentage, the amount of active compound is undetermined and can vary significantly from batch to batch, even within the same manufacturer.

 

Three. Intervention on degradation.

 

This is the criterion most formulations fail to meet, and the one with the greatest impact according to what this article describes.

 

It's worth reading the label and identifying which component is there specifically to reduce the loss. If there isn't one, the formulation acts on only one term of the equation, with the ceiling that implies.

 

Four. Number of components.

 

A formulation that lists fifteen ingredients is unlikely to contain physiologically relevant doses of each one. The number of components is not an indicator of quality, and it often indicates the opposite.

 

These four criteria can be applied to any bottle, in any pharmacy, in under a minute.

 

The formulation described below was developed to meet them, and the next section measures it against each one.

MOLVEK Triple Pathway Nitric Oxide

Three standardized botanical extracts, with no additional components.

 

Organic beetroot — 500 mg per dose. Nitrate supply through a pathway independent of the endothelial enzyme. This corresponds to the first point of intervention.

 

Grape seed extract — 150 mg per dose, standardized to ninety-five percent polyphenols. Activation and increased expression of eNOS. This corresponds to the second point.

 

Pomegranate extract — 150 mg per dose, standardized to forty percent punicalagins. Reinforcement of the endothelial antioxidant defense and reduction of superoxide load. This corresponds to the third point.

 

Format: sixty vegetable capsules. Daily dose of two capsules. Thirty days per bottle.

 

Does not contain: capsaicin, stimulants, added sugar, artificial sweeteners, gluten, soy or gelatin.

 

On the dose disclosure: the milligrams of each component are listed individually on the label. No proprietary blend is used, which is the usual practice for not revealing the actual ratio between components of differing cost.

 

On the standardization: the percentages listed correspond to the guaranteed concentration of active compound in each extract. An extract with no declared percentage may contain a minimal fraction of the compound of interest.

Check Availability Now

Consideraciones sobre tolerancia digestiva

The gastric discomfort associated with this category usually has an identifiable origin: compounds with an irritant action, mainly capsaicin, which act by stimulating sensory receptors in the digestive tract.

That stimulation is their mechanism of action, not a side effect. The sensation of heat and the gastric discomfort come from the same process: they are inseparable.

This formula contains none of those compounds. Three botanical extracts in a vegetable capsule, with no capsaicin and no stimulants.

As a result, it requires no adjustment period, no gradual dose escalation and no administration tied to specific meals. Two capsules a day, at whatever time of day is easiest to keep up.

One relevant note: consuming beet can cause a reddish discoloration of the urine in some people. This is a benign phenomenon, with no clinical significance, attributable to the vegetable's natural pigments, and it resolves once consumption stops.

It is worth pointing this out in advance to avoid unnecessary alarm.

What to expect, in what time frame, and why quitting early is the main factor behind failure

It is worth pointing out precisely what kind of product this is, because the wrong expectation is the most frequent cause of an unsatisfactory result.

It produces no perceptible effect during the first doses.

It does not create a sensation of heat, tingling or any immediate signal. It is worth repeating why: the products that produce those sensations usually do so through irritant stimulation, which is a different mechanism and bears no relation to what is described in this article.

The first reported changes are nonspecific and appear during the first weeks: less feeling of cold in the extremities, feeling more rested on waking. These are manifestations of improved peripheral perfusion.

From there on the effect is cumulative, and this has a concrete physiological explanation.

The increase in enzyme expression is not immediate. Increasing the amount of enzyme available in the cell requires the cell to synthesize it, and that is a process measured in weeks, not in hours.

And here is the feature that defines the correct use of this product:

Nitric oxide is not stored. The body produces it each day or it does not have it. Each period without production is not made up for later. There is no way to recover lost time by increasing the dose further on.

The same applies to installed capacity: if the process of increasing expression is interrupted, it does not continue from where it left off. It regresses.

Most cases of an unsatisfactory result correspond to early discontinuation, usually around the third week. That is precisely the point just before the accumulated effect begins to show in a recognizable way.

For that reason, use is framed in months and not in days.

Check Availability Now
MOLVEK Óxido Nítrico Triple Vía

Compra 2, lleva 1 gratis

Tres envases equivalen a noventa días: el período completo que cubre la garantía.

APROVECHAR OFERTA 👉🏻
Duración del plan: 90 DÍAS
Envío GRATIS

Garantía de devolución de 90 días. Sin condiciones adicionales.

Ninety days of evaluation, and why the pack comes in three

The manufacturer offers a warranty period of ninety days from receipt of the order. The figure follows a logic tied to what was explained in the previous section: it is the minimum amount of time in which a product with cumulative action should be evaluated.

A thirty-day period would be insufficient to observe the effect of a process that requires weeks of enzymatic synthesis. Offering it would guarantee in advance that most users would not get to observe anything, and would shift the cost of an incomplete evaluation onto the buyer.

The pack follows from that.

Each bottle covers thirty days of use. Ninety days of continuous use amounts to three bottles.

That is why the standard pack is not a single bottle, but the three that correspond to the full period the warranty covers. The third is provided at no cost: charging separately for the bottle needed to complete the evaluation would contradict the period offered.

Refund conditions, as reported by the manufacturer:

No return of the product is requested. No audiovisual record is requested. No minimum number of days of use is required. In case of intolerance, the warranty applies just the same, regardless of the amount consumed.

The request is processed by email, indicating the order number.

Buy 2, get 1 free

Three bottles. Ninety days. The full evaluation period.

[BUTTON: CLAIM OFFER]

Free shipping · 90-day money-back guarantee

About the Current Batch

According to information from the manufacturer, the current batch is 458 bottles, and the next one requires 6 weeks of production.

The standardized extracts are not bought on the local market: they are ordered from the supplier in advance and analyzed before bottling, as described in the section on standardization.

Distribution is exclusively through the official site. The product is not sold on Amazon, Temu or Aliexpress.

The current promotion has an end date. When it closes, the bottle returns to its regular price of $65USD.

The cause is identifiable

What is usually attributed to age corresponds, in most cases, to a specific circulatory process: a cell layer that produces less and less of a signaling molecule, and an oxidative load that degrades more and more of the little that is produced.

That process has a described mechanism, it advances progressively, and it doesn't show up on routine tests because those tests weren't designed to detect it.

But it can be identified.

And it allows for intervention at three defined points.

90-day money-back guarantee

MOLVEK Óxido Nítrico Triple Vía

Compra 2, lleva 1 gratis

Tres envases equivalen a noventa días: el período completo que cubre la garantía.

APROVECHAR OFERTA 👉🏻
Duración del plan: 90 DÍAS
Envío GRATIS

Garantía de devolución de 90 días. Sin condiciones adicionales.

Boost your circulation naturally!

VERIFICAR DISPONIBILIDAD

✔️ 90-Day Money-Back Guarantee
  • Patricia Alarcón

    Mi marido jamás escribiría esto. Llevo tres años durmiendo al lado de un compañero de cuarto. Lleva dos meses tomándolo y anoche me abrazó por la cintura mientras yo lavaba. Nada más. Me quedé quieta para que no se le pasara.

    Me gusta·Responder· ·39 min
  • Hernán Lagos

    Pedí uno solo para probar y me arrepentí a la semana. El frasco dura 30 días justos y esto no se nota en 30 días. Cuando repetí me fui derecho al pack de 3, que además sale mucho más conveniente.

    Me gusta·Responder· ·45 min
  • Esteban Cifuentes

    Lo que más me sorprendió no fue lo obvio. Fue dejar de calcular. Antes tenía que organizar la noche con horas de anticipación, como una cita médica. Eso se me fue desapareciendo solo y ni me di cuenta cuándo.

    Me gusta·Responder· ·1 h
  • Andrés Peñaloza

    Lo más raro es cómo te empieza a mirar tu señora otra vez. Como si se acordara de quién eras hace 15 años. Yo no le conté nada de esto, ella sola lo notó.

    Me gusta·Responder· ·2 h
  • Mauricio Aravena

    Seis años con la pastilla azul. Empecé esto sin mucha fe. Hace un par de semanas me di cuenta de algo raro: la caja seguía cerrada en el cajón. No la tiré ni nada, simplemente dejé de acordarme de que estaba ahí.

    Me gusta·Responder· ·3 h
  • Felipe Cáceres

    A los que llevan poco: yo casi lo dejé en la semana tres porque no sentía nada. Lo que me hizo seguir fue una tontera, dejé de despertar con las manos heladas. De ahí en adelante fue apareciendo el resto. Aguanten.

    Me gusta·Responder· ·4 h
  • Iván Sepúlveda

    Ocho años que no me despertaba con una erección de la mañana. Hace dos semanas pasó. Me quedé mirando el techo diez minutos sin poder creerlo. Uno da eso por perdido y no se lo cuenta a nadie.

    Me gusta·Responder· ·5 h
  • Verónica Maldonado

    Mi marido tiene 61 y ya se había rendido. Se lo compré y le dije que era para la circulación, sin entrar en detalles. A las cinco semanas me invitó a salir un sábado, cosa que no pasaba hace años. Con eso me basta.

    Me gusta·Responder· ·6 h
  • Ricardo Ortiz

    Llevaba años inventando excusas para no acercarme. Cansancio, la espalda, madrugar. A las cuatro semanas con esto mi mujer me tomó la mano una noche y me dijo "volviste". Eso es todo lo que voy a contar.

    Me gusta·Responder· ·7 h

APPLY DISCOUNT + FREE GIFTS AVAILABLE 

AVISO MÉDICO Y DE SALUD: La información y otro contenido proporcionado en esta página, o en cualquier material vinculado, no tiene la intención y no debe interpretarse como consejo médico, ni la información sustituye la experiencia o el tratamiento médico profesional.

Si usted o cualquier otra persona tiene una preocupación médica, debe consultar con su proveedor de atención médica o buscar otro tratamiento médico profesional. Nunca ignore el consejo médico profesional ni se demore en buscarlo debido a algo que haya leído en esta página o en cualquier material vinculado. Si cree que puede tener una emergencia médica, llame a su médico o a los servicios de emergencia inmediatamente.

VERIFICAR DISPONIBILIDAD